Eric Baudin Selected Research

Endocrine Gland Neoplasms (Cancer, Endocrine)

4/2015	Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole.
1/2014	IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Baudin Research Topics

Disease

64	Neoplasms (Cancer) 07/2022 - 08/2002
33	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 01/2002
27	Adrenocortical Carcinoma 05/2022 - 03/2005
25	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2003
16	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 01/2003
11	Pheochromocytoma 01/2021 - 11/2003
10	Paraganglioma (Paragangliomas) 01/2021 - 10/2007
8	Disease Progression 01/2022 - 02/2008
6	Neuroendocrine Carcinoma 01/2021 - 04/2011
6	Cushing Syndrome 04/2020 - 01/2006
6	Carcinoma (Carcinomatosis) 02/2012 - 12/2002
6	Lymphatic Metastasis 09/2009 - 08/2002
5	Papillary Thyroid Cancer 07/2022 - 10/2005
5	medullary Thyroid cancer 01/2021 - 05/2003
5	Carcinoid Tumor (Carcinoid) 01/2019 - 02/2002
4	Primitive Neuroectodermal Tumors (PNET) 01/2022 - 02/2016
4	Anaplastic Thyroid Carcinoma 01/2020 - 11/2004
4	Fatigue 12/2019 - 12/2011
3	Hepatocellular Carcinoma (Hepatoma) 03/2020 - 06/2006
2	Insulinoma 01/2022 - 05/2013
2	Renal Insufficiency (Renal Failure) 01/2021 - 05/2010
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021 - 01/2008
2	Endocrine System Diseases (Endocrine Diseases) 04/2020 - 09/2014
2	Dyslipidemias (Dyslipidemia) 06/2019 - 01/2016
2	Sepsis (Septicemia) 12/2017 - 04/2015
2	Stomatitis 12/2017 - 12/2011
2	Endocrine Gland Neoplasms (Cancer, Endocrine) 04/2015 - 01/2014
2	Nausea 04/2015 - 01/2012
2	Hypoglycemia (Reactive Hypoglycemia) 03/2015 - 05/2013
2	Pituitary ACTH Hypersecretion 02/2015 - 05/2011
2	Multiple Endocrine Neoplasia Type 2a (MEN 2) 09/2013 - 05/2006
2	Hypertension (High Blood Pressure) 11/2012 - 01/2012
2	Familial medullary thyroid carcinoma 04/2012 - 04/2002
2	Exanthema (Rash) 01/2012 - 12/2011
2	Adenoma (Adenomas) 03/2005 - 11/2003
2	Hyperplasia 12/2002 - 04/2002
2	Follicular Adenocarcinoma 08/2002 - 08/2002
1	Lymphoma (Lymphomas) 01/2022
1	Congenital Abnormalities (Deformity) 01/2022

Drug/Important Bio-Agent (IBA)

21	Mitotane (Lysodren)FDA Link 05/2022 - 01/2006
10	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2022 - 01/2002
9	IodineIBA 07/2022 - 12/2011
9	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 02/2002
9	Everolimus FDA Link 01/2022 - 01/2010
8	Pharmaceutical PreparationsIBA 12/2017 - 06/2008
6	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2003
6	vandetanib (ZD6474)IBA 01/2021 - 09/2011
6	Thyroglobulin FDA Link 01/2019 - 08/2002
6	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2013 - 01/2005
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 12/2010
4	Sunitinib (Sutent)FDA Link 01/2022 - 11/2012
4	Thyroid HormonesIBA 12/2021 - 08/2002
4	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021 - 10/2007
4	Chromogranin AIBA 01/2021 - 11/2003
4	PlatinumIBA 01/2021 - 09/2010
4	EnzymesIBA 01/2021 - 03/2004
4	Hormones (Hormone)IBA 01/2019 - 03/2007
3	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 06/2012
3	Biological ProductsIBA 04/2015 - 05/2003
3	Ethiodized Oil (Ethiodol)FDA Link 04/2015 - 10/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2012 - 11/2004
2	Lysine (L-Lysine)FDA Link 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2019
2	pulrodemstat besilateIBA 01/2022 - 01/2021
2	Peptide Receptors (Peptide Receptor)IBA 01/2021 - 01/2019
2	Radioisotopes (Radionuclides)IBA 01/2021 - 01/2019
2	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2020 - 04/2014
2	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2020 - 09/2011
2	AntibodiesIBA 03/2020 - 08/2012
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2019 - 08/2015
2	Interferon-alpha (Interferon Alfa)IBA 12/2017 - 01/2017
2	Ketoconazole (Nizoral)FDA LinkGeneric 04/2015 - 09/2011
2	Metyrapone FDA Link 04/2015 - 09/2011
2	Charcoal (Charbon)IBA 03/2015 - 09/2009
2	2,2- (2- chlorophenyl- 4'- chlorophenyl)acetic acidIBA 10/2014 - 06/2011
2	Tyrosine Kinase InhibitorsIBA 04/2014 - 09/2011
2	Sorafenib (BAY 43-9006)FDA Link 04/2014 - 03/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014 - 01/2008
2	Proteins (Proteins, Gene)FDA Link 05/2013 - 03/2007
2	Cisplatin (Platino)FDA LinkGeneric 06/2012 - 11/2004
2	Alanine Transaminase (SGPT)IBA 03/2012 - 02/2010
2	MetanephrineIBA 05/2010 - 10/2007
2	Capsules (Microcapsules)IBA 10/2005 - 11/2004
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022

Therapy/Procedure

32	Therapeutics 07/2022 - 08/2002
15	Drug Therapy (Chemotherapy) 05/2022 - 01/2003
10	Thyroidectomy 12/2021 - 12/2002
4	Neck Dissection (Radical Neck Dissection) 12/2021 - 05/2003
3	Radiotherapy 01/2021 - 11/2004
3	Radiofrequency Ablation 01/2019 - 04/2015
3	Lymph Node Excision (Lymph Node Dissection) 11/2012 - 05/2003
2	Contraindications 01/2021 - 01/2019
2	Aftercare (After-Treatment) 01/2018 - 06/2008
2	Combination Drug Therapy (Combination Chemotherapy) 02/2017 - 06/2012
2	Tattooing 03/2015 - 09/2009
2	Adrenalectomy 09/2011 - 05/2011
2	Hepatectomy 02/2010 - 04/2003